Alvotech issues annual equality report covering 2022

Reykjavik, iceland, may 15, 2023 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the release of its second annual equality report covering 2022.
ALVO Ratings Summary
ALVO Quant Ranking